glp 1 drugs and parkinson's disease How a 'blockbuster' treatment for diabetes obesity might slow or stop – Van Andel Institute Repurposing GLP-1 Receptor Agonists for

A statistically significant inverse correlation between IGF-1 and blood glucose levels was present before (r = -.30, P = .02) and after 8 (r = -.37, P = .007) and 16 (r = .02, P = .02) weeks of dietary treatment

It is important to be precise about what this is: a computational analysis of transcriptional signatures in cell lines

De la Cruz, A., Coy, D

OLeary, P

Consent for Publication Consent for publication is not applicable as this is a narrative review with no individual data included

Drug compounding is allowed when drugs are on the FDA's shortage list, or in circumstances when a patient can't take a version of a drug made by a pharmaceutical company and they need an alternative